Erythromycin: This medicine induces forceful contractions, stimulating gastric emptying of both solid and liquid foods
Erythromycin and related macrolides for gastroparesis To evaluate the safety and effectiveness of erythromycin or its derivatives in reducing symptoms and improving
It has been shown to enhance gastric emptying in diabetic patients with gastroparesis 4, 5 and in critically ill patients requiring mechanical ventilation
Breast-feeding How should I use this medication? Take this medication by mouth with glass of water
Delayed gastric emptying is a leading cause of complications after PPPD, occurring in up to 50% of patients
Diagnosis of gastroparesis is based on the presentation of gastroparesis-associated symptoms that exist without any gastric outlet obstruction or ulceration and delayed
Limited data exist concerning the efficacy of erythromycin in treating gastroparesis
Most physicians recommend that patients have a low-fat and low-fiber diet, eat smaller portions frequently during the day, chew food properly, eat well-cooked food, avoid alcohol and carbonated water, and drink plenty of water
This product is available in the following dosage forms: Capsule, Delayed Release
Lack of appetite
” Gastroparesis could be defined as a condition of collective symptoms of nausea and vomiting associated with bloating and early satiety plus or minus upper abdominal pain, caused by delayed gastric emptying in the absence of mechanical obstruction
The Problem
Erythromycin is used to treat certain infections caused by bacteria, such as infections of the respiratory tract, including bronchitis, pneumonia, Legionnaires' disease (a type of lung infection), and pertussis (whooping cough; a serious infection that can cause severe coughing); diphtheria (a serious infection in the throat); sexually transmitted diseases
Erythromycin may lose its effectiveness over time, and can cause side effects, such as diarrhea
Normally, the muscles of the stomach, which are controlled by the vagus nerve, contract to break up food and move it through the gastrointestinal (GI) tract
Synthetic erythromycin analogues (motilides) devoid of antibiotic properties have been developed, but have so far been disappointing; ABT229 increases the rate of gastric emptying, but with poor ERY-TAB (erythromycin delayed-release tablets) is an antibacterial product containing erythromycin base in a specially enteric-coated tablet to protect it from the inactivating effects of gastric acidity and to permit efficient absorption of the antibiotic in the small intestine
•Scintigraphic studies have shown that intravenous erythromycin accelerates gastric emptying, especially in diabetic patients and during the postoperative period when emptying is slowed
Erythromycin will not treat a viral infection such as the flu or a common cold
In patients with moderate-to-severe gastroparesis, thick or thin liquids may be recommended (e
Most common etiologies include diabetes, post-surgical and post-infectious, but in most cases it is idiopathic